Close Menu

NEW YORK (GenomeWeb) – Belgian molecular diagnostics firm Biocartis Group today reported a 9 percent decline in full-year 2016 revenues, as a drop in collaboration revenue offset strong demand for its real-time PCR-based Idylla platform and test cartridges.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.